SENTÉ Appoints Philippe Schaison to Board of Directors

Liquid error (sections/article-main line 13): invalid url input

SAN DIEGO, Calif., October 24, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced the appointment of Philippe Schaison to its Board of Directors effective immediately.

“We are thrilled to have Philippe join the SENTÉ team”, said Faheem Hasnain, Chairman of the Board of Directors of SENTÉ. “He brings a tremendous set of expertise and validation to our company during this exciting next phase of growth. Philippe is a high ranking industry veteran and will be a valuable asset in helping the company evolve into a major aesthetics contender.”

Mr. Schaison brings to SENTÉ over 20 years in the skin care industry. Currently, he is Chief Executive Officer of Syneron Candela North America and Global Executive Vice President Strategy and Business Development. Most recently he served as President of Allergan US Aesthetic and Dermatology, where he led a $2 billion U.S. Aesthetic and Dermatology business since 2013, with responsibility for Allergan’s top aesthetic brands, including Botox, Juvederm, Kybella and SkinMedica, and other leading brands. Prior to Allergan, Mr. Schaison served in leadership roles at several aesthetic businesses, including Clarins, Johnson & Johnson where he served as VP of Global Skin Care, and L’Oréal. Mr. Schaison received a Master of Business Administration in Marketing from the Hautes Etudes Commerciales (H.E.C.) in Paris, and a Doctorate in Pharmacy from the University of Paris V.

“I am excited and honored to have the opportunity to play a key role in SENTÉ’s already robust and experienced Board of Directors” said Philippe Schaison. “SENTÉ has assembled a world class team and a market disrupting technology that the aesthetics industry has been waiting for. I am looking forward to being a part of this compelling growth story and helping SENTÉ become a leading brand in the space ”.

About SENTÉ:

SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycan’s. Founded in 2007 and based in San Diego, California, further information may be found at SENTÉ products are available through its exclusive network of physicians and medically supervised spas.

SENTÉ Press Contact:

Creative Media Marketing
(212) 979-8884